With nearly 20 million new cancer cases in 2022 alone and a staggering 28.4 million projected by 2040, the urgency for improved treatments has never been greater.
While the rapid advancement of personalized treatments has transformed oncology, it has brought with it a host of new considerations, complexities, and challenges that sponsors must overcome.
This free ebook, “A Best Practice Guide for Laboratory Services in Oncology Trials” shines a light on how adopting agile, flexible practices such as adaptive trial designs, customizable assays, and highly specialized laboratory services can support an approach.
- More robust scientific and streamlined laboratory testing
- Improved regulatory compliance
- Safer, more effective treatments
Download our free ebook now to discover how an agile, customizable approach for your laboratory services will improve this aspect of your clinical trial.
Key Takeaways:
Insights into the importance of customization :
Gain a deep understanding of essential tailor-made laboratory services required for achieving clinical trial endpoints.
An agile approach for oncology trials :
Learn about oncology trial best practices in laboratory services and why it is important to build in flexibility.
Leveraging laboratory services providers’ capabilities:
Discover how you can effectively bring together outsourced laboratory services to advance oncology trials, including customized assays, a global laboratory network and more.
Specialty Lab
Our specialty laboratory solutions can fit into your current clinical development plans. Even if you are using another central laboratory provider, our agile approach and customer-centric view allows you to communicate scientist to scientist easily
Genomics
Since 1992, Cerba Research has pioneered the art of human genetic testing. Thanks to this experience, we are able to collaborate with the life science community to provide the most suitable genomic service and enhance the power of your genetic material.
Flow Cytometry
With 25 years of extensive expertise in providing flow cytometry testing for clinical trials ranging from phase I to phase III, Cerba Research has a strong track record of developing and validating custom-made flow cytometry panels.
Cell & Gene Therapy
Developing Cell and Gene Therapies requires an increased need to access expertise, knowledge, data and insights to bring the right patient to the right treatment at the right time.
Reach out to our experts and discover how we can help you transform your research and advance your clinical trials.
Contact Us